Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Venus Pharma GmbH
Werne, North Rhine-Westphalia, Germany
- Ownership
- Private
- Development stage
- Other
01
Overview
Venus Pharma GmbH (VPG) is a commercial-stage pharmaceutical company with over 130+ Marketing Authorizations across 20 countries, a strong focus on generics and specialty injectables in antibiotics and oncology, and notable global regulatory and procurement milestones, including WHO prequalification for meropenem[1][4].
- Therapeutic areas
- OncologyInfectious DiseasesOther
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
02
Partnerships
UNICEFglobal regulatory and supply partnerships
Beyond the preview
Go deeper on Venus Pharma GmbH.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Venus Pharma GmbH.